Investorideas.com newswire, news and commentary for leading sectors

Monday, March 31, 2014

Frac Water News Alert: HII Technologies, Inc. (OTCBB/OTCQB: HIIT) Reports Full Year 2013 Financial Results

HOUSTON - March 31, 2014 (Investorideas.com Newswire) HII Technologies, Inc. (the "Company"), symbol HIIT (OTCBB/OTCQB: HIIT), an oilfield services company focused on providing Water, Power and Safety Services today announced its financial results for the fiscal year and fourth quarter ended December 31, 2013.

Significant fiscal year and fourth quarter 2013 financial results for the Company included:
  • Fourth quarter 2013 revenues were approximately $4.8 million, an increase of approximately 190% from the fourth quarter 2012 revenues,
  • Fiscal year ended December 2013 revenues were approximately $14.5 million, an increase of approximately $12.8 million, or 730%, from the previous fiscal year,
  • Gross Margins averaged 26.2% for the year, and 26.9% for the fourth quarter ended December 31, 2013 resulting from improvement in operational margins from increased sales of the two newer divisions of Power and Safety covering fixed costs,
  • Adjusted EBITDAS for fiscal year 2013 was approximately $500,700 and included adjustments for one-time non-recurring expense items, non-cash and non-operational items, (EBITDAS defined as earnings before interest, depreciation, amortization, non-cash stock option expenses, and one-time non-operational expense items); a non-GAAP measure. (see tables below for a more detailed discussion),
  • Net Loss was $.03 per share on a fully diluted basis, excluding the adjusted items listed below.
The Company's full 2013 fiscal year results are set forth in its Annual Report on Form 10-K filed with the SEC on March 31, 2014.
The Company's audited revenues for the year ended December 31, 2013 represented full year fiscal results from the Company's operating subsidiaries (doing business as AES Water Solutions, South Texas Power and AES Safety Solutions) and partial-year results for the Company's AquaTex subsidiary acquired in November 2013. Pro forma 2013 revenues would have been approximately $16.7 million if the Company's acquisition of AquaTex occurred on January 1, 2013.
Each of the Company's Water, Power and Safety divisions experienced operational growth and increased revenues during 2013, as discussed below.
The Company's Water division experienced significant growth in 2013 due to increased customer base, expanded territories of operational activities and additional services offered. The November 2013 AquaTex acquisition also provided new customers and geographic expansion in South Texas' Eagle Ford Shale and the Eaglebine formation in East Texas. Additional service offerings including waste water evaporation services and flow back/well testing services which made a positive impact on the Water division's revenue growth. As previously announced, the strategic alliances with CRS Repossessing and Resource West also contributed to the Water division's 2013 growth. By partnering for these additional products and services for our Water division, the Company avoided most of the costly product development cycles and issues customarily found with new product inventions.
The Company's Safety division continued its growth in 2013 via establishing new safety engineering service sites in Ohio and West Virginia, adding customers in Texas for safety inspection as well as safety classroom training and certification programs offered. AES Safety Services also expanded its service offering to include a rapid spill response program for site clean-up and remediation after environmental occurrences.
During 2013, the Company's Power division, operating as South Texas Power (STP), augmented its fleet of oilfield mobile generator sets, acquired several new oilfield customers and added additional key employees, all of which contributed to its growth and facilitated expansion into other parts of Texas. Recently STP has developed a new operating base in the Permian basin. The Power division anticipates entering the Oklahoma market in fiscal 2014 leveraging its existing customer base and reputation in the Texas market.
Matthew Flemming, CEO of HII Technologies, stated, "While maintaining our focus in the Water, Safety and Power market segments we have expanded our services within these segments which is a business strategy we believe will continue to position us for growth. Currently, the markets we operate in have been very active for energy services and we are pleased with the organic growth that occurred in 2013." Mr. Flemming continued, "The successful integration of the AquaTex acquisition from November 2013 and the Company's continued growth and demonstrated ability to bring new technologies to our customers, is a tribute to the outstanding people who work at our Company. We are thankful for our hard working employees, and we are excited to accelerate our plans in 2014 for our stockholders."
Investorideas.com Newswire As reported in the Company's 2013 Annual Report on Form 10-K audited results, Current Assets increased by approximately $2.1 million to approximately $5.0 million from the previous quarter ended September 30, 2013. The Company's Stockholder's Equity (Total Assets minus Total Liabilities) increased by approximately $69,000 to approximately $886,000, sequentially from the previous quarter ended September 30, 2013. These increases were directly attributable to the Company's acquisition of AquaTex on November 12, 2013 and our operational performance in the fiscal year 2013.
Fourth Quarter 2013 Income Statement
The table below sets forth the summary Company's Statement of Operations, for the fourth quarter ended December 31, 2013;
Investorideas.com Newswire Adjusted EBITDAS Reconciliation Table
The following is a reconciliation of income from continuing operations attributable to the Company as presented in accordance with United States generally accepted accounting principles (GAAP) to EBITDAS.
Investorideas.com Newswire The Company anticipates releasing preliminary first quarter 2014 revenue results in April with further corporate updates and initial 2014 revenue guidance by May 2014.
For more information, managements analysis of its financial information and the Company's risk factors, please read the Company's 2013 Annual Report on Form 10-K at the Edgar web site at www.SEC.gov and www.HIITinc.com
About HII Technologies, Inc.
HII Technologies, Inc. is a Houston, Texas based oilfield services company with operations in Texas, Oklahoma, Ohio and West Virginia. By focusing on the Water, Power and Safety oilfield segments, the Company is positioned to take advantage of the anticipated, significant growth in horizontal drilling and hydraulic fracturing within the United States' active shale and unconventional "tight oil" plays. The Company's frac water supply and flow back services segment has two subsidiaries, AES Water Solutions and AquaTex, its onsite oilfield contract safety consultancy does business as AES Safety Services, and its mobile oilfield power subsidiary operates as South Texas Power (STP). HII Technologies' objective is to bring proven technologies to these operating divisions to build a long-term competitive advantage. Read more at www.HIITinc.com, www.AESwatersolutions.com, www.AquaTexUSA.com, www.AESSafetyServices.com and www.Oilfield-Generators.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements as to matters that are not of historic fact are forward-looking statements. These forward-looking statements are based on HII Technologies, Inc. ("HII")'s current expectations, estimates and projections about HII, its industry, its management's beliefs and certain assumptions made by management, and include statements regarding estimated capital expenditures, future operational and activity expectations, international growth, and anticipated financial performance in 2014. No assurance can be given that such expectations, estimates or projections will prove to have been correct. Whenever possible, these "forward-looking statements" are identified by words such as "expects," "believes," "anticipates" and similar phrases.
Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, but not limited to: risks that HII will be unable to achieve its financial, capital expenditure and operational projections, including quarterly and annual projections of revenue and/or operating income and risks that HII's expectations regarding future activity levels, customer demand, and pricing stability may not materialize (whether for HII as a whole or for geographic regions and/or business segments individually); risks that fundamentals in the U.S. oil and gas markets may not yield anticipated future growth in HII's businesses, or could further deteriorate or worsen from the recent market declines, and/or that HII could experience further unexpected declines in activity and demand for its hydraulic frac related water transfer business, its safety consultancy business or its generator and related equipment rental service businesses; risks relating to HII's ability to implement technological developments and enhancements; risks relating to compliance with environmental, health and safety laws and regulations, as well as actions by governmental and regulatory authorities. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Other important risk factors that may affect HII's business, results of operations and financial position are discussed in its most recently filed Annual Report on Form 10-K, recent Quarterly Reports on Form 10-Q, recent Current Reports on Form 8-K and in other Securities and Exchange Commission filings. Unless otherwise required by law, HII also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. However, readers should review carefully reports and documents that HII files periodically with the Securities and Exchange Commission.
Because such statements involve risks and uncertainties, many of which are outside of HII's control, HII's actual results and performance may differ materially from the results expressed or implied by such forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Other important risk factors that may affect HII's business, results of operations and financial position are discussed in its most recently filed Annual Report on Form 10-K, recent Quarterly Reports on Form 10-Q, recent Current Reports on Form 8-K and in other Securities and Exchange Commission filings. Unless otherwise required by law, HII also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. However, readers should review carefully reports and documents that HII files periodically with the Securities and Exchange Commission.
Contact:
Matthew Flemming, HII Technologies, Inc. +1-713-821-3157
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers.
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
HIIT disclosure: March 2013: two thousand per month for profile and news publication, renewed August 2013: five hundred per month for news publication
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Biotech News Alert: MANAGEMENT OF SUNSHINE BIOPHARMA (OTCQB: SBFM) ALARMED BY THE RECENT WORLD HEALTH ORGANIZATION REPORT THAT CANCER IS ON THE RISE

Montreal, Quebec, Canada - March 31, 2014 (Investorideas.com Biotech Newswire) Sunshine Biopharma Inc. (OTCQB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer has issued a response to the recently released reports by the World Health Organization and the Pancreatic Cancer Action Network.

"We are very pleased with the progress we have made thus far in our efforts to re-domicile the Company in Canada," said Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma. "We are anxious to complete the re-domiciling process as we have attendant growth and financing opportunities that we believe are available to us once we have completed this action. This is important for the Company’s business strategy overall and for our Adva-27a anticancer drug candidate as we advance towards clinical trials for multidrug resistant breast cancer and pancreatic cancer."
According to "World Cancer Report 2014" issued in February by the World Health Organization, cancer is on the rise and has become a leading cause of death worldwide, accounting for 8.2 million deaths in 2012. Lung cancer accounted for 1.59 million deaths and breast cancer represented half a million deaths. The report also says that cancer cases are expected to rise significantly, "It is expected that annual cancer cases will rise from 14 million in 2012 to 22 million within the next two decades."
Additionally the Pancreatic Cancer Action Network released a special report entitled "The Alarming Rise of Pancreatic Cancer Deaths in the United States: Why We Need to Stem the Tide Today". The report noted that "T(t)he alarming findings presented in the report include the fact that by the year 2020, and possibly as early as 2015, pancreatic cancer will move from the fourth leading cause of cancer death to the second leading cause of cancer death in the United States."
"We are alarmed and impassioned by these trends to move vigorously ahead with our clinical development of Adva-27a for aggressive forms of cancer," said Dr. Steve N. Slilaty, Chief Executive Officer of Sunshine Biopharma. "The Company is planning a Phase I clinical trial of Adva-27a for pancreatic cancer in parallel to the Phase I clinical trial of Adva-27a for multidrug resistant breast cancer to be conducted at McGill University's Jewish General Hospital in Montreal (Canada)."
Sunshine Biopharma recently reported that it has initiated the construction of mouse xenograft models for pancreatic cancer as part of the plans of positioning Adva-27a for clinical development for pancreatic cancer in parallel with multidrug resistant breast cancer. Adva-27a is Sunshine Biopharma's lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant breast cancer cells, small-cell lung cancer cells, uterine sarcoma cells and pancreatic cancer cells (Published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012). Adva-27a is currently in the IND-Enabling stage of development. The original U.S. patent covering Adva-27a was issued on August 7, 2012 under U.S. patent number 8,236,935.
Safe Harbor Forward-Looking Statements
To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.
For Additional Information Contact:
Camille Sebaaly, CFO
Sunshine Biopharma Inc.
Direct Line: 514-814-0464
camille.sebaaly@sunshinebiopharma.com
www.sunshinebiopharma.com
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: SBFM has renewed effective December 3,2013 with Investorideas for six months of news publication and general public awareness of the company news and technologies and products in the biopharma markets ( one hundred thousand shares of 144 stock per 3 month period for a total of six months ) More disclaimer info: http://www.investorideas.com/About/Disclaimer.aspBC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

NXT-ID (OTCQB:NXTD) Tech News Alert: Witness the Evolution of Smart: Press Conference and Launch Event for Wocket(TM), a Next Generation Smart Wallet, to Be Held in New York City, May 28th: Pre-Ordering Available Following Event

SHELTON, CT - March 31, 2014 (Investorideas.com Newswire) NXT-ID, Inc. (OTCQB: NXTD), a biometric authentication company focused on the growing m-commerce market, announces the first corporate launch event and press conference for its next generation smart wallet, Wocket™, designed to replace all the cards in your wallet. The event will take place in New York City on May 28th.

The marketing event and press conference will give consumers and media a first-hand look at the Wocket™ Smart Wallet, the Wocket™ Card, its new logo and brand images, new consumer video and new packaging. Following the event, consumers will be able to pre-order Wocket™ online.
First consumer videos will be released online mid- April, prior to the event .The location and time for the press conference and launch to be held in New York will be announced shortly in upcoming marketing press releases.
Introducing Wocket™ will be Mr. Gino Pereira, Chief Executive Officer of NXT-ID, Inc., accompanied by David Tunnell, Chief Technology Officer and Advisory Board member, Mr. Lawrence Flanagan, the former Global Chief Marketing Officer of MasterCard. Mr. Flanagan managed a $1.5 billion budget, directed marketing strategies in more than 50 countries and helped launch the company's hugely successful, "Priceless" advertising campaign.
In anticipation of the launch event and press conference, Mr. Pereira said, "Wocket™ is truly the evolution of smart devices for consumers that are concerned about security in the payment industry. I believe Wocket™ addresses security and convenience better than any of our competitors coming to market. There is growing demand and consumer interest for a product like this that protects privacy and prevents identity theft and there are a number of features that makes Wocket™ stand out from the crowd. Wocket™ is biometrically secure, so only you can access it with your own unique combination of voice, PIN or pattern; each time your card is used the information on your card is zeroed, so it is useless to someone else who tries to use it or steal it; Wocket™ can store up more than 10,000 cards so all the loyalty cards and gift cards that you have at home, and can never find when you need them, are now easily accessible. Most importantly Wocket™ is separate from your phone, so if your phone is stolen, lost or runs out of battery, you can still use Wocket™, with its full functionality, just as you would your wallet."
"At a time when smartphones are stolen and hacked daily, consumers are concerned about storing all their payment information and identity on their phone. Wocket™ will evolve as the payment industry evolves. Wocket™ is just the beginning of our MobileBio™ suite of products that include technologies for data encryption to further reduce credit card fraud similar to that recently experienced by Target and other retailers. Future versions of Wocket™ will include a wider range of communication technologies, such as 4G and NFC, protected by our proprietary encryption technologies "
He went on to say, "Our goal is to stay ahead of the curve by bringing consumers the smartest payment, authentication and identity security solutions possible. Ten years from now we want consumers to remember this launch and talk about the first generation Wocket™ they purchased. Wocket™ has the capability to change the way people make credit card transactions worldwide."
Wocket™ is a smart wallet in the same vein as the smart phone and smart watch. NXT-ID is introducing its innovative, patent-pending Wocket™ as the next natural step in the evolution of smart devices. Wocket™ is a next generation smart wallet designed to replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.
Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket™. More than 10,000 cards, records, coupons, etc. and 100 voice commands can also be stored on Wocket™.
The Wocket product FAQ is available to consumers and media at http://nxt-id.com/wocket-faq/
Interested consumers can also sign up for product info and news alerts in anticipation of the product. http://www.thewocket.com/, http://www.wocketwallet.com/
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
800 665-0411
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013 :Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous services
More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Friday, March 28, 2014

Privacy VS. Security; the Challenge and the Opportunity - how Biometrics and Cybersecurity are Changing the Future; (NASDAQ:APEI) (OTCQB:NXTD) (OTCBB:PSID) (OTCQB:VSYS)(OTCQB:IMSC) News

New York, NY - March 28, 2014 (www.investorideas.com newswire) Investorideas.com, an investor research and news portal covering leading sectors including technology and defense releases video and commentary from its recent Security and Defense Conference , GameChanging Technologies: The Face and Future of Security”, held in New York on March 11, 2014.
This panel of industry experts discusses the current state of the security and defense industry, and explores where it's headed in 2014 and beyond including authentication, biometrics, biodefense, cyber security.
In regards to cyber, Roger Cressey a Partner with Liberty Group Ventures, LLC said." Here's the problem with cybersecurity; nobody knows what it is. It is all things to all people right now and you may have one specific slice of the cybersecurity pie but I can tell you the government is still trying to figure out what it is For example , the Department of Defense is going to request $5 Billion dollars for the next fiscal year budget and even they aren't sure where all that money is going to go , they just know they need to spend more.
He went on to say later in the session, "In cyber, the technology is changing at light speed and the regulatory and legal construct is still stuck in a dial up environment. So we all need to remember that Washington and the even at the State level is way behind the curve in terms of what kind of regulatory and legal framework need to be in place to reflect this new reality."
Scott Greiper, President and Founding Partner Secure Strategy Group notes , " everybody in cyber ; the user and the provider is playing defense. Nobody is playing offense. We are looking for companies with technologies that play offense ."
He also said in terms of biometrics, it's all about identity management "We have moved from bring your own device to bring your own identity."
In terms of opportunity he stated , "We prefer to work with small public companies because the results of our efforts and management's effort is visible every day and that's where you can get wealthy in this space; is in the small public market area."
Janice Kephart, Founder and CEO of The Secure Identity and Biometrics Association (SIBA) told the audience , " What I think in 2014, is that this could be very much the year of biometric but much will depend on the education and the acceptance of both the public and private sector. "
Panel:
MODERATOR: ROGER CRESSEY, Liberty Group Ventures
PANELISTS: SCOTT GREIPER, Secure Strategy Group; MARTY MARTIN, Crane & Crane Consulting; JANICE KEPHART, The Secure Identity and Biometrics Association (SIBA)
Video: https://www.youtube.com/watch?v=shXCEWuo9oY
Visit the conference page to learn more:
http://www.investorideas.com/Conference
See more speaker bios and PowerPoint presentations /disclaimers and disclosures and more
http://www.investorideas.com/Conference/Speakers.asp
Speaker Bios:
Roger Cressey is a Partner with Liberty Group Ventures, LLC in Arlington VA, a risk and crisis management firm specializing in cyber security, campus security and sports security. He most recently served as a Senior Vice President at Booz Allen Hamilton, supporting the firm's cyber security practice in the Middle East. Prior to joining Booz Allen, he was President and Founder of Good Harbor Consulting LLC, a security and risk management consulting firm.
Mr. Cressey's government service included senior cyber security and counterterrorism positions in the Clinton and Bush Administrations. At the White House, he served as Chief of Staff of the President's Critical Infrastructure Protection Board from November 2001 - September 2002. He also served as Deputy for Counterterrorism on the National Security Council staff from November 1999 to November 2001. He was responsible for the coordination and implementation of US counterterrorism policy and managed the US Government response to multiple terrorism incidents, including the Millennium terror alert, the USS COLE attack, and the September 11th attacks.
From 2004 - 2013, he served as an on-air counterterrorism analyst with NBC News, appearing frequently on NBC Nightly News, The Today Show, MSNBC and CNBC.
Prior to his White House service, Mr. Cressey served in the Department of Defense, where he worked on US defense strategy and the review of Pentagon war plans. From 1991-1995, he served in the Department of State working on Middle East security issues, including serving as a member of the US delegation to the multilateral track of the Arab-Israeli peace process talks.
His overseas experience includes serving as a Pol-Mil officer with the US Embassy in Israel and with UN peacekeeping operations in Somalia and the former Yugoslavia. While in the former Yugoslavia, Cressey was part of a United Nations team that planned the successful capture of the first individual indicted for war crimes in Croatia. From 2001 - 2006, he taught a graduate course on U.S. counterterrorism policy at Georgetown University. He also served as a Fellow at the Center on Law and Security at New York University.
He received his B.A. in Political Science from the University of Massachusetts at Lowell and an M.A. in Security Policy Studies from The George Washington University. Roger is the recipient of the State Department's Meritorious and Superior Honor Awards and the Defense Department's Exceptional Civilian Service Award.
Scott Greiper, President and Founding Partner Secure Strategy Group
Mr. Greiper is the President and Founding Partner of Secure Strategy Group. He has had a distinguished 15-year career in the security and defense technology sectors as both a research analyst and investment banker, and is known as a thought leader in the industry. Before forming Secure Strategy Group, he was a Managing Director at Legend Merchant Group and Head of the firm's Convergent Security Group, which provided capital, strategic advisory and M&A services to growth companies in the security and defense technology markets. Previously, Mr. Greiper was a Principal and Senior Analyst at C. E. Unterberg, Towbin, where he covered public companies in the Global Security industry and was consistently ranked as one of the top analysts in the sector. He has worked with a range of industry leaders and is a frequent guest speaker and moderator at conferences and seminars across the country. Mr. Greiper attended the Executive MBA program at Columbia University and holds a B. A. in Economics from The University of Chicago. He is a member of the FBI InfraGard program, BENS (Business Executives for National Security), ASIS (American Society for Industrial Security) and NYSSA (New York Society for Security Analysts).
Janice Kephart, Founder and CEO of The Secure Identity and Biometrics Association (SIBA)
Janice recently returned from a Special Counsel position with the Senate Judiciary Committee, where she was asked to testify and then return to staff to support the national, border and identity security aspects of the now Senate-passed immigration reform legislation. Ms. Kephart is an internationally recognized border and ID security expert, who served as counsel to the 9/11 Commission and was a key author of the Staff Monograph, 9/11 and Terrorist Travel as well as the immigration and identity security-related facts and recommendations in the 9/11 Commission Report.
More info: http://www.sibassoc.org/#!aboutsiba/csgz
Janice speaks regularly at conferences, to international media, publishes articles and opeds around the world, and has testified before Congress 16 times on issues of border and ID security.
Marty Martin, CEO of Crane & Crane Consulting
Marty Martin has an accomplished career which includes service with the CIA, NSA, and the U.S. Army. He has developed invaluable insight, managerial experience, and relationships across the U.S. Government and many foreign governments and intelligence services at the highest levels. He is the CEO of Crane & Crane Consulting, LLC where he leads the firm's expansion and growth. He previously served as a Senior Executive for the International Oil Trading Company (IOTC), a multi-billion dollar enterprise with activities in Iraq , Jordan , Libya , Russia and the Caribbean . He also played a central role in HBO's Manhunt, a 2013 Emmy awarding winning documentary. Mr. Martin's experience includes over 29 years of U.S. Government service including U.S. Special Forces, the National Security Agency, and the CIA, culminating in several years as a member of the CIA's Senior Intelligence Service. From 2004 through 2007 he served as Chief of Station in a strategic country in the Middle East in one of the most senior assignments in the Near East Division. He managed a multi-million dollar budget, strategic programs, personnel, and families in high threat environment. His experience includes representing the CIA at the highest levels in foreign countries, the U.S. Executive Branch, the U.S. Congress, U.S. Military, on all intelligence and policy matters concerning the agency's operations. In 2002 he was selected by the Director of Central Intelligence as the senior executive and operational manager to lead the Agency's global effort to neutralize Al-Qaida. In that role, he interacted at the highest levels of the U.S Government, including the White House, FBI, Homeland Security, NSA, Congress, and various branches of the U.S. Military, on a daily basis. During this specific period the lion's share of the perpetrators of 9/11 were nullified.
Visit the conference page to learn more:
http://www.investorideas.com/Conference
Presenting Companies at the Conference :
American Public University System (NASDAQ:APEI) - Dr. Clay Wilson is the Program Director for Cybersecurity
Dr. Clay Wilson is the Program Director for Cybersecurity graduate studies at the American Public University, where he has responsibility for designing new courses. He is past Program Director for Cybersecurity Policy at the University of Maryland University College (UMUC), where he oversaw development of new graduate-level courses. Dr. Wilson is also a former analyst for national defense policy at the Congressional Research Service where he analyzed cyber intelligence reports for the U.S. Congress and NATO committees on net-centric warfare, cybersecurity, nanotechnology, and other vulnerabilities of high-technology military systems and critical infrastructures. More info: http://www.apu.apus.edu/academic/faculty-members/bio/4438/clay-wilson
About American Public University System (NASDAQ:APEI) American Public University System, winner of the Sloan Consortium's Ralph E. Gomory Award for Quality Online Education and first three-time recipient of Sloan's Effective Practice Award, offers more than 90 online degree programs through American Public University and American Military University. APUS's relevant curriculum, affordability and flexibility help more than 100,000 working adults worldwide pursue degrees in a diverse variety of subjects. For further information, visit www.apus.edu. http://www.apus.edu/about-us/facts.htm
NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB:NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms led by the Wocket™; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.thewocket.com/, http://www.wocketwallet.com/
NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/ , http://3d-id.net/
Tekcapital, Ltd. - The World's Largest University Network for Open Innovation. Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 3,300+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage.
PositiveID Corporation (OTCBB:PSID) develops unique medical devices and molecular diagnostic systems, focused primarily on diabetes management, rapid medical testing and airborne bio-threat detection. Its wholly-owned subsidiary, MFS, is focused on the development of microfluidic systems for automated preparation of and performance of biological assays.
Viscount Systems (OTCQB:VSYS), a Canadian manufacturer of advanced physical access control systems combines traditional access control performance with cyber security (true convergence of logical and physical access) to increase security while driving down facility costs to secure offices, hospitals, critical infrastructure, schools, banks, and manufacturing. Our unique offering satisfies new US Federal Government standards for increased protection of facilities from external threats. http://viscount.com/
Implant Sciences (OTCQB:IMSC) is the leader in next generation Explosives Trace Detection (ETD), and established counter-terrorism technology that detects and identifies threats from the small amounts left behind after a person handles explosives. Implant Sciences' security solutions are used worldwide for aviation, public transport, customs, air cargo, critical infrastructure, ports/ borders, and emergency response. The Company has thousands of units deployed to over 50 countries, and its trace detectors have been successfully used at the Sochi Olympics, Beijing Olympics, the Universiade Games, and the Special Olympics.
In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. With advanced capabilities including superior sensitivity, automatic internal calibration, rapid clear-down, ush button maintenance, and administration of trace detection. Company's handheld QS-H150 and desktop QS-B220 simplify the use, maintenance, and administration of trace detection. www.implantsciences.com
Silanis Technology: Businesses and government organizations of all sizes choose Silanis Technology when electronic signatures matter. With more than 600 million documents processed every year, Silanis eSignLive™ is the most widely used esignaturesolution around the world. Thousands of organizations, big and small, including the leading banks, insurers, credit providers, pharmaceutical and government agencies trust eSignLive as their platform to make business digital. Silanis has been providing secure electronic signature solutions to government for over 15 years, and understands the unique security and signing needs of Federal DoD and civilian agencies, as well as state and local governments. Siilanis stands behind the longest running implementation of esignatures in the US government, and the largest signature initiative ever undertaken in government. Organizations that have standardized on Silanis include the US Joint Chiefs of Staff; the US Army with an enterprise license for 1.6 million personnel; and the General Services Administration (GSA), which mandated the use of esignatures for GSA Schedules contracts. www.silanis.com
About InvestorIdeas.com: www.investorideas.com
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country
Contact info:
Cali Van Zant cvanzant@investorideas.com 800. 665. 0411
D. Van Zant dvanzant@investorideas.com 800. 665. 0411
800-665-0411 - Source: www.Investorideas.com

Exploring the NIST Cybersecurity Framework and Implementation; Kiersten Todt & Roger Cressey, Liberty Group Ventures

New York, NY - March 28, 2014 (www.investorideas.com newswire) Investorideas.com, an investor research and news portal covering leading sectors including technology and defense releases video and commentary from its recent Security and Defense Conference , GameChanging Technologies: The Face and Future of Security”, held in New York on March 11, 2014. Kiersten Todt and Roger Cressey of Liberty Group Ventures discuss the NIST Cybersecurity Framework and Implementation and how corporations need to treat cyber risk equal to other corporate risk.

Under Executive Order, President Obama directed The National Institute of Standards and Technology (NIST) to "work with stakeholders to develop a voluntary framework for reducing cyber risks to critical infrastructure." Kiersten Todt and Roger Cressey supported the NIST in drafting the Cybersecurity framework and soliciting input from the private sector. This session explores the framework, its implementation in key critical infrastructure sectors, and the impact of these cybersecurity policies on the industry and emerging businesses.
“The key intention is to normalize cyber risk behavior” says Kiersten Todt . The call to actions on the part of companies of all sizes is to take on this framework and be a part of what the framework looks like in its next generation.”
Session : Exploring the NIST Cybersecurity Framework and Implementation-
SPEAKERS:, Kiersten Todt and Roger Cressey Liberty Group Ventures
Video : https://www.youtube.com/watch?v=seRpNxXLoSU
PowerPoint/Slide : http://www.investorideas.com/Conference/keynotes/Kiersten-Todt.asp
Visit the conference page to learn more:
http://www.investorideas.com/Conference
Speaker Bios:
Roger Cressey is a Partner with Liberty Group Ventures, LLC in Arlington VA, a risk and crisis management firm specializing in cyber security, campus security and sports security. He most recently served as a Senior Vice President at Booz Allen Hamilton, supporting the firm's cyber security practice in the Middle East. Prior to joining Booz Allen, he was President and Founder of Good Harbor Consulting LLC, a security and risk management consulting firm.
Mr. Cressey's government service included senior cyber security and counterterrorism positions in the Clinton and Bush Administrations. At the White House, he served as Chief of Staff of the President's Critical Infrastructure Protection Board from November 2001 - September 2002. He also served as Deputy for Counterterrorism on the National Security Council staff from November 1999 to November 2001. He was responsible for the coordination and implementation of US counterterrorism policy and managed the US Government response to multiple terrorism incidents, including the Millennium terror alert, the USS COLE attack, and the September 11th attacks.
From 2004 - 2013, he served as an on-air counterterrorism analyst with NBC News, appearing frequently on NBC Nightly News, The Today Show, MSNBC and CNBC.
Prior to his White House service, Mr. Cressey served in the Department of Defense, where he worked on US defense strategy and the review of Pentagon war plans. From 1991-1995, he served in the Department of State working on Middle East security issues, including serving as a member of the US delegation to the multilateral track of the Arab-Israeli peace process talks.
His overseas experience includes serving as a Pol-Mil officer with the US Embassy in Israel and with UN peacekeeping operations in Somalia and the former Yugoslavia. While in the former Yugoslavia, Cressey was part of a United Nations team that planned the successful capture of the first individual indicted for war crimes in Croatia. From 2001 - 2006, he taught a graduate course on U.S. counterterrorism policy at Georgetown University. He also served as a Fellow at the Center on Law and Security at New York University.
He received his B.A. in Political Science from the University of Massachusetts at Lowell and an M.A. in Security Policy Studies from The George Washington University. Roger is the recipient of the State Department's Meritorious and Superior Honor Awards and the Defense Department's Exceptional Civilian Service Award.
Kiersten E. Todt
President and Managing Partner
Liberty Group Ventures, LLC (LGV)
Kiersten Todt is the President and Managing Partner of Liberty Group Ventures, LLC (LGV). She develops risk and crisis management solutions for infrastructure, emergency management, cybersecurity, higher education, and homeland security clients in the public, private, and non-profit sectors. She has served in senior positions in both the executive and legislative branches of government. Ms. Todt has commented on homeland security and sport security issues in multiple media outlets, including MSNBC, NPR, Bloomberg, and The Wall Street Journal. Her work on sport security has been published in two editions of The International Centre for Sport Security Journal.
Prior to LGV, Ms. Todt was a partner at Good Harbor Consulting and was responsible for the company's North America crisis management practice, which had a concentration in cyber security. Clients included states and quasi-public institutions, maritime entities, small and large businesses, and college and university systems. Before joining Good Harbor, she worked for Business Executives for National Security (BENS) and was responsible for integrating the private sector into state and local emergency management capabilities; she also developed and executed federal and regional port and cyber security projects. Prior to BENS, she was a consultant for Sandia National Laboratories and worked with the California Governor's Office and Bay Area Economic Forum to develop the homeland security preparedness plan for the Bay Area. Ms. Todt was also an adjunct lecturer at Stanford University.
Ms. Todt served as a Professional Staff Member on the U.S. Senate Committee on Governmental Affairs (now the Committee on Homeland Security and Governmental Affairs); she worked for the Committee Chairman, Senator Joseph Lieberman, and was responsible for drafting the bioterror, infrastructure protection, emergency preparedness, and science and technology directorates of the legislation that created the Department of Homeland Security. She also served as Senator Lieberman's Appropriations Director and managed his drug policy portfolio.
Before working in the Senate, Ms. Todt served in Vice President Gore's domestic policy office and was responsible for coordinating federal resources with locally-defined needs, specifically focusing on energy challenges in California and housing issues. She was also the senior advisor on demand-reduction issues to Director Barry. R. McCaffrey at the Office of National Drug Control Policy (ONDCP).
Ms. Todt graduated from Princeton University, with a degree in public policy from The Woodrow Wilson School of Public and International Affairs. She holds a master's degree in Public Policy from the John F. Kennedy School of Government at Harvard University and was selected to be a Presidential Management Fellow in 1999. She earned the Outstanding Service Award at ONDCP.
Visit the conference page to learn more:
http://www.investorideas.com/Conference
About InvestorIdeas.com: www.investorideas.com
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy, food and beverage stocks and Latin American stocks.
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894 . Global investors must adhere to regulations of each country
Contact info:
Cali Van Zant cvanzant@investorideas.com 800. 665. 0411
D. Van Zant dvanzant@investorideas.com 800. 665. 0411
800-665-0411 - Source: www.Investorideas.com

Wednesday, March 26, 2014

TSX Biotech Stocks to Watch (TSX.V: QPT) (TSX:ONC; NASDAQ:ONCY) (TSX.V:IMV) AEZS) (TSX: AEZ).; Innovative Ovarian Cancer Treatments

New York, NY - Point Roberts, WA - March 26, 2014 (Investorideas.com Newswire) Investorideas.com, a global news source for leading sectors including biotech and pharma issues a sector snapshot of TSX biotech stocks targeting ovarian cancer as part of their product pipeline. Stocks mentioned include Quest PharmaTech Inc. (TSX.V: QPT), Oncolytics (TSX:ONC; NASDAQ:ONCY) , Immunovaccine, Inc. (TSX.V:IMV) and Aeterna Zentaris Inc. (AEZS) (TSX: AEZ).

There are 17,000 women living with ovarian cancer in Canada. It is estimated that this year in Canada, 2,600 women will be newly diagnosed with ovarian cancer. Ovarian cancer is the 5th most common cancer for women and is the most fatal women's cancer, says Ovarian Cancer Canada.
According to reported statistics, more than 22,000 women are diagnosed with ovarian cancer in the United States annually, and more than 12,000 die each year.
In February news reports said, "As many as one in four hundred women test positive for the BRCA-1 gene, often called the "breast cancer gene."
They have not only a significantly increased risk for breast cancer, but also for ovarian cancer.”
http://www.wlbz2.com/story/news/nation/2014/03/23/6788983/
Leading U.S. biotech stocks have had a massive bull run this year, although recently the sector has had a correction on concerns of valuations. However some of the smaller microcap stocks have not seen the same volatile trading patterns.
For investors looking at TSX biotech stocks and life sciences stocks, a recently released interview in the Life Sciences Report (TSLR) with Roadmap Capital explains the difference in valuations in US and TSX biotech stocks best.
"TLSR: Why invest primarily in Canadian companies? If you were exclusively a resource investor, and looking for deep value as well as growth, this is understandable, but in the life sciences sector, where the goal is huge growth, why limit yourself to Canadian stocks? Is it about tax advantages? National pride?
HC: I should point out that the new fund has made investments in the U.S. already, and will continue to do so. But we are focusing primarily in Canada. Frankly, it's about where we see the best opportunities and risk/reward ratio. There's no shortage of innovation in Canada, but the long, drawn-out bear market that the Canadian tech and healthcare sectors went through for much of the last decade has left many interesting companies valued at levels far below what is available in other countries. To give you an example, we're putting money into a company with a $2.5M pre-money valuation. Comparable companies in the States would be valued in the $30-40M pre-money range currently. And we have invested a small amount of money into a private stem cell company called Hemostemix. It is raising money at a $25M pre-money valuation, when its best public comparables in the U.S. trade at valuations in the $200—400M range. It comes down to where we see the best valuation opportunities and risk/reward for our investors right now. - "
Source : http://www.equities.com/editors-desk/stocks/healthcare/apply-market-savvy-to-bear-market-debris-uncover-biotech-treasures-cleland-and-ireland cPhase 2 biotech tsx ovarian cancer co's
Sector Snapshot : Ovarian Cancer Treatment
Quest PharmaTech Inc.'s ( TSX.V: QPT).lead product, Oregovomab is currently completing a phase II clinical trial in both Italy and the U.S., is used in combination with standard chemotherapy in ovarian cancer patients. It is also being tested in combination with other immunotherapeutic agents for use in treating pancreatic cancer patients.
From a previous interview with Investorideas.com, Madi R. Madiyalakan, Ph.D., Chief Executive Officer, said "Our technology is focused on the immunotherapy of cancer. We utilize tumor directed monoclonal antibodies to activate the specific immunity; however we recognize that successful therapy requires orchestrated combination with chemotherapy, photodynamic therapy and select additional immune modulators or adjuvants. Our lead product, Oregovomab, which is currently completing a phase II clinical trial in both Italy and the U.S., is used in combination with standard chemotherapy in ovarian cancer patients. We are also initiating a clinical trial using Oregovomab in combination with an immuno-adjuvant, Hiltonol® (TLR3 agonist), with standard chemotherapy. Oregovomab is also being tested in combination with other immunotherapeutic agents for use in treating pancreatic cancer patients. Our pipeline also includes proprietary antibodies against other cancer markers, most notably MUC1, PSA and HER2. We expect to advance our MUC1 targeting antibody into the clinic in the coming year. MUC1 expressing cancers include many commonly occurring solid cancers such as breast, pancreatic and lung cancers. "
Six month chart:
Investorideas.com Newswire Oncolytics (TSX: ONC; NASDAQ:ONCY)
Oncolytics Biotech Inc. is focused on the development of oncolytic viruses for use as cancer therapeutics. The Company’s lead product, REOLYSIN®, a proprietary formulation of the human reovirus, is currently in late stage (Phase III) clinical testing in head and neck cancers. REOLYSIN® has been utilized in nearly thirty clinical trials including translational, Phase I, Phase II (single arm and randomized), and Phase III studies in a broad range of cancer indications. Ovarian cancer : OG-0186H (NCI / GOG Trial) Phase II Intravenous Administration of REOLYSIN® in Combination with Paclitaxel for Patients with Persistent or Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer US- status is ongoing.
Six month chart:
Investorideas.com Newswire Immunovaccine, Inc. (TSX.V: IMV)
According to the company's financial report released March 17th, "During 2013, scientists provided compelling evidence that the human immune system could be trained to destroy cancer cells," said Dr Marc Mansour, chief operating officer. "These findings support the idea that immunotherapies have the potential to shift cancer from a life threatening disease to a chronic and manageable condition.
"Several large pharmaceutical companies also announced during the year that vaccines will play an important role in the development of their cancer therapy programs. These industry trends parallel our own approach to the development of therapeutic cancer vaccines. With our planned trials in ovarian cancer, glioblastoma and breast cancer expected to begin this year, IMV is well placed to participate in this rapidly evolving industry."
Highlights of 2013 and First Quarter of 2014
  • DPX-Survivac - Positive data from Immunovaccine's completed Phase I study were presented at multiple venues throughout the year, including the 2013 ASCO annual meeting. We believe that these findings represent some of the strongest immune responses against a cancer target seen to date.
Based on these promising data, Canada's NCIC Clinical Trials Group (NCIC) agreed to sponsor and conduct a randomized Phase II study of DPX-Survivac in patients with advanced ovarian cancer. We expect this study to be initiated in 2014 with results available in 2017. Immunovaccine also signed an agreement with the University of Rome for a multicenter Phase II study of DPX-Survivac in glioblastoma patients. The study is expected to begin in 2014 and its costs will be assumed by this University.
  • DPX-0907 - Immunovaccine agreed to allow use of DPX-0907 in a Phase I/II study of breast and ovarian cancer patients at the Busto Arsizio Hospital in Italy. The study, which will be funded by Busto Arsizio, is expected to be initiated in 2014.
Six month chart :
Investorideas.com Newswire Aeterna Zentaris Inc. (AEZS) (TSX: AEZ)  is a biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. Their pipeline includes Zoptarelin doxorubicin for Ovarian and prostate cancer, currently in Phase 11. Zoptarelin doxorubicin is a targeted cytotoxic peptide conjugate which is a hybrid molecule composed of a synthetic peptide carrier and a well-known cytotoxic agent, doxorubicin. The design of this product allows for the specific binding and selective uptake of the cytotoxic conjugate by the LHRH receptor-positive tumors. The binding of conjugate molecule zoptarelin doxorubicin to cancerous cells that express these receptors results in its accumulation in the malignant tissue. This binding is followed by internalization and retention of the cytotoxic drug, doxorubicin, in the cells. Therefore, since they target specific cells, cytotoxic conjugates are postulated to be more effective and have less side-effects than the respective non-conjugated/non-linked cytotoxic agents in inhibiting tumor growth.
Six month chart
Investorideas.com Newswire TSX Life Sciences Snapshot
Life Sciences Markets at a Glance – YTD February 28, 2014
February   2014
TSX Venture (TSXV)
TSX
TSXV and TSX
Number of Issuers
69
39
108
QMV (C$)
2,153,038,500
63,319,048,526
65,472,087,027
New Listings
2
-
2
Equity Capital Raised (C$)
126,738,564
10,823,900
137,562,464
Number of Financings
18
2
20
Volume Traded
295,773,521
238,949,246
534,722,767
Value Traded (C$)
162,114,369
3,263,237,459
3,425,351,827
# of Trades
82,324
277,538
359,862
http://www.tmx.com/en/listings/sector_profiles/life_sciences.html
According to the TSX, nearly $3 billion of equity capital was raised by life sciences companies on TSX and TSXV in 2013.
About InvestorIdeas.com:
InvestorIdeas.com is a global news source for investors following leading business sectors including biotech, tech, mining, mobile, energy, water, defense and security, renewable energy and Latin American stocks.
Sign up for our free news alerts
http://www.investorideas.com/Resources/Newsletter.asp
Become an Investorideas.com Member http://www.investorideas.com/membership/
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: QPT.V, a public company, has engaged Investorideas.com for public relations services for four thousand a month retainer fee.
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Global investors must adhere to regulations of each country.
800-665-0411 - Source - www.Investorideas.com

Tuesday, March 25, 2014

Tech News Alert: Say Goodbye to Passwords; NXT-ID (OTCQB:NXTD) Patents a Universal Authentication Method to Replace Passwords

SHELTON, CT - March 25, 2014 (Investorideas.com Newswire) NXT-ID, Inc. (OTCQB: NXTD), a biometric authentication company focused on the growing mobile commerce market, announced today that it has submitted a patent application for a universal and adaptable authentication and data exchange method. As a follow-up to U.S. provisional patent application No. 61/802,681, NXT-ID has filed patent application 14/217289 for universal authentication and data exchange method, system and service.

The patent is a significant step forward in NXT-ID's vision to provide its proprietary MobileBio® authentication to a number of applications including financial transactions. MobileBio® enables users to identify themselves to a variety of other devices from a single device carried or worn by an individual.
In the MobileBio® ecosystem, devices know each other from a history of communication between one another. This history builds trust between devices by utilizing another NXT-ID invention, dynamic pairing. Since each device is dynamically paired with one another, it maintains a history of trust to secure its communications. When a user authenticates themselves with a local device such as a phone, watch, ring or a smart wallet, the user is also authenticating with other devices and applications that it encounters. This technology will enable users to seamlessly, securely access devices such as doors, phones, laptops, applications, entertainment systems, even remote services using a single device worn on a person.
"This technology enables users to unlock virtually anything, all from a single device that simply knows who you are," says David Tunnell, CTO of NXT-ID. "This invention supports current authentication methods such as passwords, as well as serves as a bridge to newer forms of authentication such as multi-factor authentication to promote universal security within the internet-of-things. Passwords are never forgotten, kept safe within an electronic vault that can also generate and send strong passwords to automatically login to devices and applications over a variety of communication methods such as Bluetooth and NFC (Near Field Communications)."
"This patent adds to a number of forthcoming technologies that help build our intellectual portfolio in the MobileBio® wearable and mobile markets," says Gino Pereira, CEO of NXT-ID. "We are building products to identify that you are uniquely you. The technology promotes inter-awareness in terms of identity, location, context and utility with secure methods that are dynamic, changing with every new session, and thus difficult to be spoofed."
About NXT- ID Inc. - Mobile Security for a Mobile World
NXT-ID, Inc.'s (OTCQB: NXTD) innovative MobileBio™ solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio™ suite of biometric solutions that secure consumers' mobile platforms. NXT-ID's wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/
Forward-Looking Statements for NXT-ID
This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward- looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.
Contact:
Investor Inquiries:
Kirin Smith
ProActive Capital Group
Direct: 646 863 6519
800 665-0411
Disclaimer/ Disclosure: The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. Disclosure: November 2013 :Investorideas is compensated by NXTD: five thousand per month for news publication and syndication and is long 144 shares from previous services
More info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.

Monday, March 24, 2014

Mining Stock Alert: SilverCrest (TSX: SVL) (NYSE MKT: SVLC) Announces 2013 Financial Results Cash Flow from Operations of US$26.1 million ($0.24 per share) Net Earnings US$8.5 million ($0.08 per share)

Vancouver, British Columbia - March 24, 2014 (Investorideas.com Mining Stocks Newswire) SilverCrest Mines Inc. (TSX:SVL) ( NYSE MKT: SVLC) is pleased to announce its audited consolidated financial results for the fourth quarter and year ended December 31, 2013. The fourth quarter and 2013 year end financials results reflect a one-time non-cash deferred tax accounting adjustment of $5.8 million as a result of the enactment of the Mexican Tax Reform. All financial information is prepared in accordance with IFRS and all dollar amounts are expressed in U.S. dollars unless otherwise specified. The information in this news release should be read in conjunction with the Company's audited consolidated financial statements for the year ended December 31, 2013 and associated management discussion and analysis ("MD&A") which are available from the Company's website at www.silvercrestmines.com and under the Company's profile on SEDAR at www.sedar.com.

2013 YEAR END FINANCIAL HIGHLIGHTS :
  • Cash flow from operations (1) $26.1 million ($0.24 per share)
  • Cash operating cost per silver equivalent ounce sold (2) $7.78 (Ag:Au 60.5:1)
  • Revenues reported $54.9 million
  • Mine operating earnings $28.9 million
  • Deferred tax - Mexican mining royalty $5.8 million (non-cash IFRS accounting entry)
  • Net earnings $8.5 million ($0.08 per share)
  • Cash and cash equivalents $14.4 million (at Dec. 31, 2013)
  • Working capital $25.4 million (at Dec. 31, 2013)
  • Scotiabank Credit Facility $40.0 million fully available (at Dec. 31, 2013)
N. Eric Fier, President and COO stated; "2013 was another successful year for SilverCrest, notwithstanding the lower precious metals price environment. The Santa Elena mine delivered strong production and operating cost performance throughout 2013 which allowed SilverCrest to deliver robust financial results. Management are pleased that Santa Elena achieved a cash operating cost of $7.78 per silver equivalent ounce sold compared to Company guidance of $8.50 and an all-in sustaining cash cost per silver equivalent ounce sold (2) of $13.05 which also beat Company guidance of $13.45. SilverCrest maintained its strong balance sheet through disciplined cost management and securing a $40 million credit facility with Scotiabank. SilverCrest will continue to focus on delivering strong operating results and optimizing our operating cash flow as we complete the Santa Elena Expansion and increase production in 2014 to approximately 3.3 million to 3.6 million silver equivalent ounces (Ag:Au 60:1)."
Investorideas.com Newswire Fourth Quarter ended December 31, 2013
During the fourth quarter, the Company recorded a one-time non-cash deferred tax accounting adjustment of $5.8 million as a result of the enactment of the Mexican Tax Reform. The Company has taken the position that the 7.5% mining royalty is an income tax in accordance with IFRS for financial reporting purpose, as it is based on a measure of revenue less certain specified costs. On substantial enactment, a taxable temporary difference arises, as property, plant and equipment and exploration and evaluation assets have book basis but no tax basis for purposes of the royalty. The Company has recognized a deferred tax liability of $5.8 million as at December 31, 2013 in respect of this royalty. This deferred tax liability will be drawn down to $nil as a reduction to tax expense over the life of mine as the Santa Elena Mine and its related assets are depleted or depreciated.
Net loss was $4,094,410 ($0.04 per share basic) for the fourth quarter compared with net earnings of $13,616,028 ($0.14 per share basic) in 2012. The net loss in the fourth quarter was primarily attributed to lower revenue resulting from significantly lower realized prices and the non‐cash deferred tax accounting adjustment of $5.8 million as a result of the recently enacted Mexican Tax Reform.
Silver and gold revenue totaled $12,866,617, (2012 - $18,243,732) in the fourth quarter. Silver sales were a quarterly record of 208,200 ounces including capitalized underground ounces (2012 - 171,714), 21% higher than the same period in 2012. The foregoing, combined with a 37% lower average realized price at $20 (2012 - $32) per ounce, resulted in 23% less silver revenue. Total gold sales were 8,220 ounces includes capitalized underground ounces (2012 - 8,444) or 3% below 2012. The Company sold 6,576 (2012 - 6,755) ounces of gold at an average realized price of $1,250 (2012 - $1,706) per ounce. The foregoing, 27% decline in realized price, combined with a decline in the ounces of gold sold, resulted in 29% less gold revenue. The Company delivered 1,644 gold ounces (2012 - 1,689) under the Sandstorm Purchase Agreement at $350 per ounce.
Cost of sales amounted to $5,185,211 (2012 - $5,156,489). Cash cost per silver equivalent ounce sold amounted to $7.68, Ag:Au 61.6:1 (2012 - $8.05, Ag:Au 55.6:1). The decrease in cash cost per silver equivalent ounce sold is driven generally by lower mining contractor costs related to a reduction in waste removal. As the Santa Elena Open Pit nears the end of its life, the strip ratio dropped to 1.63:1 in the fourth quarter compared to 3.07:1 for the same period in 2012.
General and administrative expenses increased by 37% to $2,885,989 (2012 - $2,208,355) primarily due to an increase in remuneration and other corporate expenses. Remuneration increased by 37% to $1,581,482 (2012 - $1,158,076) with the addition of new corporate personnel in Q1, 2013, and higher bonuses paid in December to management and employees. Tradeshows and travel increased by 184% to $331,601 (2012 - $116,768) due to an increase in trade show attendance and an accelerated investor relations program. Mexico corporate expenses increased by 47% to $259,488 (2012 - $176,440), with additional tax, legal and corporate activity.
Current income tax expense amounted to $1,580,000, compared to a recovery of $3,494,000 in 2012. For fiscal 2012, the $23.2 million Hedging Facility cash settlement was deductible for Mexican income taxes. Deferred tax expense amounted to $5,420,000 (2012 - $781,000), primarily attributed to a non‐cash accounting adjustment in relation to the Mexican Tax Reform. On December 11, 2013, the Mexican government enacted a tax reform to introduce a mining royalty effective January 2014.
Year ended December 31, 2013
Net earnings were $8,479,263 ($0.08 per share basic) for the year ended December 31, 2013, compared with $30,475,744 ($0.33 per share basic) in 2012. The decrease in net earnings was primarily driven by a decrease in revenue resulting from lower realized prices and lower gold sales combined with higher tax expense recorded compared with 2012 (attributed to the eligible deduction for income tax purposes in 2012 of the Hedging Facility cash settlement and the non‐cash accounting adjustment in 2013 of $5.8 million in relation to the Mexican Tax Reform).
Silver and gold revenue totaled $54,893,651 (2012 - $70,520,085) for fiscal 2013, which includes $53,354,062 (2012 - $63,456,934) received on a cash basis.
SilverCrest sold 751,633 ounces of silver including capitalized underground ounces (2012 - 588,312), 28% higher compared to fiscal 2012. The foregoing, combined with a 27% lower average realized price at $23 (2012 - $32) per ounce, resulted in 7% less silver revenue for the year. SilverCrest sold 30,487 ounces of gold including capitalized underground ounces (2012 - 34,834), 12% lower than fiscal 2012. From this total, the Company sold 24,389 (2012 - 21,383) ounces of gold at an average realized price of $1,392 (2012 - $1,703) per ounce. The foregoing, 18% decline in realized price resulted in 7% less gold revenue than in 2012. The Company delivered 6,097 gold ounces (2012 - 6,967) to Sandstorm at $350 per ounce, and, as the MBL Hedge Facility was settled in 2012, there were no gold deliveries (2012 - 6,484) at $926.50 per ounce.
Cost of sales amounted to $19,895,374 (2012 - $18,307,681). Cash cost per silver equivalent ounce sold amounted to $7.78, Ag:Au 60.5:1 (2012 - $7.39, (Ag:Au 54.3:1), 2013 corporate market guidance estimate was $8.50 per silver equivalent ounce, (Ag:Au 55:1). The increase in 2013 cash cost per silver equivalent ounce sold was driven by higher mining contractor costs, higher processing expenses, and greater general administrative costs from annual salary and benefit increases for mine site personnel.
All-in sustaining cash cost per silver equivalent ounce sold was $13.05, Ag:Au 60.5:1. Company guidance for 2013 was $13.45 per silver equivalent ounce sold.
Current income tax expense amounted to $5,450,000 (2012 - $4,156,000), which relates to the estimate of annual tax payable from Santa Elena operations. The Company has paid a total of $4.7 million related to 2013 income taxes, $3.1 million by offset of Mexican value added taxes receivable, and $1.6 million by offset of 2012 income taxes refund. Deferred tax expense amounted to $7,418,000 (2012 - $1,261,000), primarily attributed to a non ‐ cash accounting adjustment of $5.8 million in relation to the Mexican Tax Reform and recognizing an income tax deduction on 2013 Santa Elena exploration drilling and related costs, which were capitalized for book purposes.
Exchange loss on translation to United States dollars amounted to $1,989,460 (versus an exchange gain of $561,523 in 2012), due to the significant weakening of the Canadian dollar against the United States dollar during fiscal 2013. The financial results of the Company’s Canadian operations were translated at US$1.00 = CAD$0.9949 at December 31, 2012, and US$1.00 = CAD$1.0636 at December 31, 2013.
OUTLOOK FOR 2014
Santa Elena Targets
  • Achieve estimated 2014 production guidance of 1.3 million – 1.5 million ounces of silver and 34,000 – 36,000 ounces of gold, for an aggregate of 3.3 million – 3.6 million ounces of silver equivalent, Ag:Au 60:1.
  • Achieve estimated cash operating cost of $8.50 - $9.50 per silver equivalent ounce sold, Ag:Au 60:1.
  • Complete construction of new conventional 3,000 tpd CCD/MC mill facility in early Q2 2014 - Budget for 2014 is $14 million.
  • Complete underground decline development of main ramp to enable physical access to ore starting on level 525m -Budget for 2014 for underground development and equipment purchases is $12 million.
Sonora Project Targets
  • Ermitaño Property – initial mapping, sampling and exploration drilling of targets - Budget for 2014 is $550,000.
La Joya Project Targets
  • Complete evaluation of certain technical aspects of the project to Pre Feasibility Study level.
  • Complete a core drilling program of approximately 20 holes for in-fill drilling of preliminary pit-constrained resources (Preliminary Economic Assessment level) with subsequent metallurgical work. Budget for 2014 is $1 million.
  • Complete staged payments of $1.8 million under the La Joya agreements to acquire 100% of the 12 mineral concessions under option.
The Qualified Person under National Instrument (NI 43-101) Standards of Disclosure for Mineral Projects for this News Release is N. Eric Fier, CPG, P.Eng, President and Chief Operating Officer for SilverCrest Mines Inc., who has reviewed and approved its contents.
SilverCrest Mines Inc. (TSX: SVL; NYSE MKT: SVLC)
is a Canadian precious metals producer headquartered in Vancouver, BC. SilverCrest’s flagship property is the 100%-owned Santa Elena Mine, located 150 km northeast of Hermosillo, near Banamichi in the State of Sonora, México. The mine is a high-grade, epithermal silver and gold producer, with an estimated life of mine of 8 years and cash costs of $11 per ounce of silver equivalent (55:1 Ag:Au) for the open pit heap leach and underground mine. SilverCrest anticipates that the new 3,000 tonnes per day conventional mill facility at the Santa Elena Mine should recover an average annual rate of 1.5 million ounces of silver and 32,800 ounces of gold over the current reserve. Major expansion and construction of the 3,000 tonnes per day conventional mill facility is nearing completion and is expected to significantly increase metals production at the Santa Elena Mine (open pit and underground) in 2014 and beyond. Exploration programs continue to make new discoveries at Santa Elena and also have rapidly advanced the definition of a large polymetallic deposit at the La Joya property in Durango State with stated resources nearing 200 million ounces of Ag equivalent.
FORWARD-LOOKING STATEMENTS
This news release contains "forward-looking statements" within the meaning of Canadian securities legislation and the United States Securities Litigation Reform Act of 1995. Such forward-looking statements concern the Company’s anticipated results and developments in the Company’s operations in future periods, planned exploration and development of its properties, plans related to its business and other matters that may occur in the future. These statements relate to analyses and other information that are based on expectations of future performance, including silver and gold production and planned work programs. Statements concerning reserves and mineral resource estimates may also constitute forward-looking statements to the extent that they involve estimates of the mineralization that will be encountered if the property is developed and, in the case of mineral reserves, such statements reflect the conclusion based on certain assumptions that the mineral deposit can be economically exploited.
Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors which could cause actual events or results to differ from those expressed or implied by the forward-looking statements, including, without limitation: risks related to precious and base metal price fluctuations; risks related to fluctuations in the currency markets (particularly the Mexican peso, Canadian dollar and United States dollar); risks related to the inherently dangerous activity of mining, including conditions or events beyond our control, and operating or technical difficulties in mineral exploration, development and mining activities; uncertainty in the Company’s ability to raise financing and fund the exploration and development of its mineral properties; uncertainty as to actual capital costs, operating costs, production and economic returns, and uncertainty that development activities will result in profitable mining operations; risks related to reserves and mineral resource figures being estimates based on interpretations and assumptions which may result in less mineral production under actual conditions than is currently estimated and to diminishing quantities or grades of mineral reserves as properties are mined; risks related to governmental regulations and obtaining necessary licenses and permits; risks related to the business being subject to environmental laws and regulations which may increase costs of doing business and restrict our operations; risks related to mineral properties being subject to prior unregistered agreements, transfers, or claims and other defects in title; risks relating to inadequate insurance or inability to obtain insurance; risks related to potential litigation; risks related to the global economy; risks related to the Company’s status as a foreign private issuer in the United States; risks related to all of the Company’s properties being located in Mexico and El Salvador, including political, economic, social and regulatory instability; and risks related to officers and directors becoming associated with other natural resource companies which may give rise to conflicts of interests. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in the forward-looking statements. The Company’s forward-looking statements are based on beliefs, expectations and opinions of management on the date the statements are made. For the reasons set forth above, investors should not place undue reliance on forward-looking statements.
The information provided in this news release is not intended to be a comprehensive review of all matters and developments concerning the Company. It should be read in conjunction with all other disclosure documents of the Company. The information contained herein is not a substitute for detailed investigation or analysis. No securities commission or regulatory authority has reviewed the accuracy or adequacy of the information presented.
Contact:
Fred Cooper (Investor Relations)
J. Scott Drever (CEO)
Telephone: (604) 694-1730
Fax: (604) 694-1761
Toll Free: 1-866-691-1730
Email: info@silvercrestmines.com
Website: www.silvercrestmines.com
Address: Suite 501 - 570 Granville Street
Vancouver, BC Canada V6C 3P1
Published at Investorideas.com Newswire
Disclaimer / Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: SilverCrest Mines has compensated Investorideas.com for the distribution and publishing of this news release (annual news publication 9700) http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

InvestorIdeas.com Newswire